Topic: psoriasis
Contact: Mick Kulikowski mick_kulikowski@ncsu.edu 919-515-8387 North Carolina State University In a surprising finding, researchers at North Carolina State University have discovered the critical impo ... morePeople with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke than those without the condition, new research shows. Source: Reuters Heal ... more
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive th ... more
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating pati ... more
Reaching a 90% improvement score was more common among those who received ustekinumab, but both drugs were able to achieve at least 50% improvement in all patients. Medscape Medical News ... more
Stelara tops Enbrel in head-to-head comparison and requires fewer injections, researchers say Source: HealthDay Related MedlinePlus Topics: Medicines, Psoriasis ... more
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce ab ... more
The 2010 OneMedForum, taking place through Jan. 14 in San Francisco, features presentations from over 100 emerging life science and healthcare companies. One company presenting at the conference is Sa ... more
A recently approved drug, Stelara, is more effective than a more established drug, Enbrel, in treating moderate to severe psoriasis, according to a new study. ... more
Stelara tops Enbrel in head-to-head comparison and requires fewer injections, researchers say ... more
VBL Therapeutics announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, ... more
InNexus Biotechnology Inc. (TSX.V: IXS) , a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL „¢) technology, announced ... more
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. ... more
Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability ... more
Researchers hope to harness mind's reaction to medication Source: HealthDay Related MedlinePlus Topic: Psoriasis ... more
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. The December issue of Mayo Clinic W ... more
Researchers hope to harness mind's reaction to medication ... more
Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published ... more
Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to a new study. Early resul ... more
Celgene Corporation (NASDAQ:CELG) announced clinical data from an investigational Phase IIb, double-blind, placebo-controlled study of apremilast (CC-10004) in patients with moderate-to-severe plaque- ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week ... more
For our readers that may not have already seen this, here's Sen Harry Reid (D-BS) opining that Republicans who oppose ObamaCare are akin to folks that opposed an end to slavery, women's right to vote ... more
Contact: Tracy Vineis 617-914-6524 GCI Health CAMBRIDGE, Mass. December 7, 2009 Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in ... more
Ten years of clinical trials have shown adalimumab to be safe for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and juvenile idiopathi ... more
Provectus Announces Preliminary Phase 2 Data For PH-10 In Its Psoriasis And Atopic Dermatitis Trials
Provectus Pharmaceuticals, a company specializing in oncology and dermatological therapeutics, has announced preliminary Phase II data for its drug candidate to treat psoriasis and atopic dermatitis. ... more
Psoriasis High Blood Pressure Bipolar Disorder /div ... more
Neuherberg, November 20, 2009. Scientists of Helmholtz Zentrum Mnchen and the Center of Allergy and Environment (ZAUM) of Technische Universitt Mnchen have discovered a new type of immune cells - the ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week ... more
Beginning Thursday, Nov. 19, 2009, the International Psoriasis Council (IPC) will host its second symposium at Baylor University Medical Center in Dallas. The two-day conference brings together dermat ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time in new re ... more
Psoriasis Osteoporosis Hypertension /div ... more
A first-of-its-kind symposium has convened today that brings together U.S. and Latin American dermatologists in an effort to elevate the global understanding of psoriasis and its treatment. ... more
PhotoMedex, Inc. (Nasdaq: PHMD) a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. ... more
Ragweed Allergy Atrial Fibrillation Psoriasis /div ... more
Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new g ... more
Source: American Academy of Dermatology Related MedlinePlus Topic: Psoriasis ... more
Persistent inflammation and the activation of the immune system is the key pathological mechanism affecting many long-term conditions, such as rheumatoid arthritis, psoriasis, ulcerative colitis, and ... more
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-1 ... more
Psoriasis Type 2 Diabetes High Blood Pressure /div ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III ... more
After a long delay, Centocor Ortho Biotech #8217;s psoriasis drug Stelara has been approved by the U.S. Food and Drug Administration. Stelara is intended to treat moderate to severe plaque psoriasis, ... more
The U.S. Food and Drug Administration approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. Plaque psoriasis is an immune system disorder tha ... more
The FDA has approved ustekinumab subcutaneous injection for the treatment of moderate to severe plaque psoriasis in adults. Medscape Medical News ... more
Helps block overproduction of skin cells ... more
"The Misperception That Clinical Trial Data Reflect Long-term Drug Safety" is the title of a commentary in this week's Archives of Dermatology. The authors focused on one particular drug - Raptiva ( ... more
The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a ... more
Enbrel (etanercept), Wyeth's biological treatment for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis, is now available as a new easy-to-use pre-filled auto-injector de ... more
Chronic inflammation represents the key pathogenic event of many diseases, autoimmune rheumatic diseases, such as psoriasis, inflammatory bowel diseases, asthma, multiple sclerosis, atherosclerosis, a ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF ... more
A study shows that people with severe psoriasis have altered brain responses to expressions of disgust, a phenomenon that scientists believe might be an acquired coping mechanism. Medscape Medical N ... more
New research suggests that the brains of some psoriasis patients may adapt to cope with the body image and self-esteem issues that can accompany the skin disorder. ... more
People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without ... more
A new computational method has proven its usefulness in counting duplicated sequences in human genomes and in initially assessing their content. Duplicated segments have been linked with several types ... more
Nails are the tough flat structures that provide form and shape to the tips of fingers and toes. They improve grip of fine objects. Discoloured nails are a sign of allergic disorders, infections or d ... more
New research suggests that the brains of some psoriasis patients may adapt to cope with the body image and self-esteem issues that can accompany the skin disorder. ... more
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, medica ... more
People with psoriasis €“ an often distressing dermatological condition that causes lesions and scaly patches on the skin €“ are less likely to react to looks of disgust by others than people without ... more
First demonstration of clinical efficacy for novel class of resolvin therapeutics BEDFORD, MA August, 24, 2009 #8212; Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today ... more
Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), a development-stage oncology and dermatology biopharmaceutical company, has added Mount Sinai School of Medicine as its second and final site for its expa ... more
Overactive Bladder Psoriasis (Ages 18-65) Alcoholism (Opiate Dependence) /div ... more
August is Psoriasis Awareness Month. Visit the psoriasis health topic page, which includes an interactive health tutorial. ... more
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has initiated a new Phase 2 clinical trial of PH-10 for psoriasis involving dai ... more
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms. ... more
Many of the approximately one million Canadians(i) living with psoriasis may be faced with physical or emotional challenges as they struggle with public misperceptions and stigmas of this painful, ch ... more
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms. ... more
July 7, 2009 - FasterCures today announced its support of Research Revolution, 23andMe's just launched effort that aims to change the way we learn about how genes and environment affect the causes and ... more
Psoriasis, a chronic skin disorder caused by the immune system, affects 1%-2% of white individuals. Although there are a number of treatments, the chronic recurrent nature of the disorder means more e ... more
Treatment with anti-tumor necrosis factor agents is recognized as a risk factor for tuberculosis in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondyl ... more
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylos ... more
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from ... more
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from ... more
As well as being an independent risk factor for cardiovascular disease, psoriasis is also associated with an increased risk of cerebrovascular disease and peripheral arterial disease, a new case-contr ... more
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, periphe ... more
Inflammation looks like common thread, researcher says. Source: HealthDay ... more
People with psoriasis may need to pay close attention to their cardiovascular risks, a new study shows. ... more
The Australian Government will subsidise new forms of several drugs already listed on the PBS and will extend the listing of Adalimumab as an alternative treatment for severe psoriasis. ... more
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such ... more
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such ... more
A major challenge in treating autoimmune disorders has been suppressing inflammatory attacks on body tissues without generally suppressing immune function. Now, a drug from Chinese medicine shows pote ... more
A drug derived from an herb used in Chinese medicine for 2,000 years is the first to target specific cells overactive in rheumatoid arthritis, psoriasis, and other autoimmune diseases. ... more
PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, announced the availability ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, has achieved yet another goal by completion of patients' enrollment in its phase II Psoriasis trial. Appr ... more
Smoking IBS (Irritable Bowel Syndrome) Psoriasis Cystic Fibrosis Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Hyperte ... more
Vitamin D may slow the progressive decline in the ability to breathe that can occur in people with asthma as a result of human airway smooth muscle (HASM) proliferation, according to researchers at th ... more
In a randomized controlled trial, ultraviolet B phototherapy given at home or in an outpatient setting were equally safe and effective in the treatment of psoriasis, both clinically and for quality of ... more
UVB therapy at home is safe, effective and more convenient, researchers say. Source: HealthDay ... more
For patients with psoriasis, treatment with ultraviolet B (UVB) at home is as effective and as safe as conventional hospital based phototherapy, concludes a study published on bmj.com today. Patients ... more
For patients with psoriasis, treatment with ultraviolet B at home is as effective and as safe as conventional hospital based phototherapy, suggests a new study. ... more
Home treatment of the skin ailment psoriasis with ultraviolet light lamps is at least as safe and effective as conventional phototherapy at hospitals or clinics, according to new research. ... more
Abbott has announced new data showing that HUMIRA® (adalimumab) is as effective in patients with moderate to severe psoriasis at 16 weeks with or without the concurrent use of topical therapy.1 The ... more
Ultraviolet light is a proven treatment for psoriasis, one of humanity's oldest known diseases. Sunshine can also beat back the chronic autoimmune disorder of the skin. But explaining light's therapeu ... more
In a prospective study of US female nurses, psoriasis was independently associated with an increased risk for diabetes and hypertension. Medscape Medical News ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a new article. ... more
A new Cochrane review finds that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. ... more
Scientists find that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. ... more
Gastroesophageal Reflux Disease (GERD) Migraine and Cluster Headaches Pain Irritable Bowel Syndrome (IBS) Psoriasis Atopic Dermat ... more
US scientists who followed 78,000 women for 14 years found that having psoriasis, an immune system condition that appears on the skin in the form of thick, red scaly patches, was linked to a hig ... more
US scientists who followed 78,000 women for 14 years found that having psoriasis, an immune system condition that appears on the skin in the form of thick, red scaly patches, was linked to a hig ... more
Researchers suspect chronic inflammation is common thread among all 3 conditions. Source: HealthDay ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the J ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the J ... more
In response to a study in JAMA's Archives of Dermatology indicating a link between psoriasis and an increased risk of diabetes and hypertension, Ellen Mason, Cardiac Nurse at the British Heart Foundat ... more
In response to a study in JAMA's Archives of Dermatology indicating a link between psoriasis and an increased risk of diabetes and hypertension, Ellen Mason, Cardiac Nurse at the British Heart Foundat ... more
Women who have the chronic skin condition psoriasis appear to be at higher risk of getting diabetes and high blood pressure, a new study shows. ... more
Chronic plaque psoriasis is the most common type of psoriasis and is characterised by redness, thickness and scaling. First line management of chronic plaque psoriasis is with topical treatments, incl ... more
Genentech, Inc. announced a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market. The company's decision is based on the association of Raptiva with an increas ... more
Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor α (anti-TNFα) agents, which block signaling molecules that induce inflammation, improve the sy ... more
Efalizumab (Raptiva), used for the treatment of psoriasis, will no longer be available in the United States because of the risk for progressive multifocal leukoencephalopathy. Medscape Medical News ... more
Drug manufacturer acts after link found to rare brain infection. Source: HealthDay ... more
Genentech on Wednesday announced the phased voluntary withdrawal of psoriasis drug Raptiva (efalizumab) from the US market "based on the association of [the drug] with an increased risk of progressive ... more
Genentech on Wednesday announced the phased voluntary withdrawal of psoriasis drug Raptiva (efalizumab) from the US market "based on the association of [the drug] with an increased risk of progressive ... more
Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market. The company is taking thi ... more
Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor ± (anti-TNF±) agents, which block signaling molecules that induce inflammation, improve the sympto ... more
Low-dose acitretin (a drug used to treat skin psoriasis) therapy appears to reduce nail psoriasis symptoms, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archive ... more
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the ... more
Data from the 2008 Psoriasis Patient Study from Consumer Health Sciences, were presented at the 67th Annual Meeting of the American Academy of Dermatology in San Francisco on March 10, 200 ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA "hotspots " that may reveal how genetic differences ... more
Source: American Academy of Dermatology ... more
A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that do ... more
A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that do ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA #8220;hotspots #8221; that may reveal how genetic difference ... more
Promius Pharma, LLC, has launched Scytera „¢ (coal tar) Foam 2% for the treatment of chronic psoriasis, a skin disease that affects approximately 7.5 million Americans according to The National Psoria ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA "hotspots" that may reveal how genetic differences among indi ... more
Patients with dermatological disease often find it difficult to participate in patient support groups.Online support options may be particularly helpful in these cases.MedPage Today reports a small st ... more
Medical News Today is pleased to announce the launch of a new Eczema / Psoriasis channel. The section will include news on skin dryness, recurring rashes, psoriatic plaques and psoriatic arthritis p ... more
According to Archives of Dermatology, psoriasis patients receive valuable educational, psychological and social support from online support communities. Archives of Dermatology is a JAMA (Journal of ... more
Psoriasis is associated with elevated leptin levels independently of obesity, metabolic syndrome or female gender, Taiwanese researchers report in the December issue of the Archives of Dermatology. ... more
Hello, everyone. We hope your weekend was refreshing, although we imagine there are some among you with sore backs after spending time shoveling snow. Nonetheless, this is a short week, so there will ... more
Experts are urging that patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease. ... more
The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives jo ... more
The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives jo ... more
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than pe ... more
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than pe ... more
New data presented today at the 'Gene to Clinic' meeting taking place at the Royal College of Physicians in London, England, reinforce Enbrel's ability to clear skin in patients with psoriatic arthrit ... more
Psoriasis affects 2-3% of people in the UK and can create both physical and psychological distress. Psychological discomfort is made worse by the visible nature of the condition where ... more
Janssen-Cilag announced that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of adults with moderate to severe plaque psoriasis from the Europea ... more
Genentech, Inc. (NYSE: DNA) announced that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopath ... more
Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to severe plaque psoriasis from the European Commit ... more
Traditional Chinese therapy proved helpful in relieving skin scaling, hardening, study finds. Source: HealthDay ... more
A randomized controlled trial showed that topical indigo naturalis ointment treatment significantly reduced scaling and erythema without adverse events in patients with plaque-type psoriasis. Medsca ... more
The University of Alabama at Birmingham (UAB) Center for Education and Research on Therapeutics (CERTs) has won a $2.2 million federal grant to study the risks and benefits of a newer class of medicin ... more
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephal ... more
Traditional Chinese therapy proved helpful in relieving skin scaling, hardening, study finds ... more
According to a study published in the November issue of Archives of Dermatology, an effective treatment for plaque-type psoriasis can be found in traditional Chinese medicine. Yin-Ku Lin, M.D. ... more
An ointment made from indigo naturalis, a dark blue plant-based powder used in traditional Chinese medicine, appears effective in treating plaque-type psoriasis, according to a report in the November ... more
A study shows 74% of patients had clearance or near clearance of psoriasis after 12 weeks' treatment with indigo naturalis ointment, a Chinese herbal remedy. ... more
GPs and Dermatologists have a new treatment option for scalp psoriasis with the launch of Xamiol® (pronounced "zamiol"), a once-daily gel formulation containing the proven combination of the Vitamin ... more
Dermipsor Ltd, a leading clinical-stage drug development company focusing on novel therapies for the dermatology market, reports detailed analysis of the Phase 2b clinical trial results for its lead p ... more
EPG Health Media this week launched a 'World Psoriasis Day' supplement on its public health website http://www.epgpatientdirect.org. The temporary feature is intended to raise awareness of the annual ... more
Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects peo ... more
Rheumatologists, dermatologists and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects peop ... more
Canada to Ban Baby Bottles Made With Bisphenol A Democratic Fundraiser Gets Unapproved Multiple Myeloma Drug Psoriasis Drug Raptiva Gets Black Box Warning ... more
Medicaid Expenditures Will Rise Sharply in Coming Years: Report Democratic Fundraiser Gets Unapproved Multiple Myeloma Drug Psoriasis Drug Raptiva Gets Bla ... more
Psoriasis Drug Raptiva Gets Black Box Warning on Infections Recalled Cribs Pose Suffocation and Entrapment Hazard 'Stayin' Alive' May Help Save Lives ... more
The U.S. Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephal ... more
The FDA has ordered a "black box" warning for the psoriasis drug Raptiva about the risk of potentially life-threatening infections. ... more
The agency is adding labeling changes, including a boxed warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephalopathy, or PML, that may develop ... more
The U.S. Food and Drug Administration announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephalopathy ... more
A New Jersey arbitrator ruled that a former Amgen sales rep can proceed with a wrongful termination claim against the biotech, a decision that may have implications for other whistleblowers who work i ... more
Dermipsor Ltd, a clinical-stage leading drug development company focusing on novel therapies for the dermatology market, announces signing a Cooperative Research and Development Agreement with the VA ... more
Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiol ... more
Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiol ... more
Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiol ... more
Genentech, Inc. (NYSE: DNA) announced that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 7 ... more
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had ... more
The biotech is sending a letter to healthcare professionals about the case of a 70-year-old man who was being treated for psoriasis for more than four years with its med, and developed a rare brain in ... more
An emulsion formulation foam of clobetasol propionate 0.05% is safe and effective for treating moderate to severe atopic dermatitis and mild to moderate plaque-type psoriasis in patients ages 12 years ... more
The NPPAC-2008 recognizes the many diverse and emerging issues involved with psoriasis raised by the Filipinos with Psoriasis around the Philippines. ... more
Synvista Therapeutics, Inc. (Amex: SYI) announces that it has received approval from the Israeli Ministry of Health to begin a Phase 2 trial of a topical formulation of SYI-2074 in ... more
LEO Pharma has at the EADV Conference in Paris unveiled a new weapon in its long-running campaign to improve psoriasis management and treatment outcomes. ... more
Expe #114ime #110t #97l D #114 #117g Usteki #110 #117m #97b bests E #110b #114el i #110 3-Mo #110th T #114i #97l; B #117t lo #110ge #114-Te #114m Res #117lts U #110k #110ow #110 An experimental dru #1 ... more
The experimental drug Ustekinumab has trumped Enbrel in a three-month trial, but longer-term results are unknown. WebMD Health News ... more
An experimental drug called ustekinumab shows better treatment results than an established drug, Enbrel, for treating moderate to severe plaque psoriasis in a new trial. ... more
New findings from a Phase 3 multicenter, randomized head-to-head study comparing ustekinumab and Enbrel(R) (etanercept) for the treatment of moderate to severe psoriasis showed ustekinumab super ... more
Data demonstrating the significant positive impact of Enbrel on the quality of life of psoriasis patients were presented today at the European Academy of Dermatology and Venereology (EADV) Congress, P ... more
The health care giant released results of a Phase III study showing ustekinumab was just as safe and effective as the top-selling med sold by Amgen and Wyeth, which has a 75 percent share of the marke ... more
Abbott's HUMIRA® (adalimumab) significantly reduces levels of C-reactive protein (CRP) in adult patients with moderate to severe plaque psoriasis, according to a post-hoc analysis presented today at ... more
The University of Iowa filed a lawsuit this week against Amgen for allegedly using it patented biotechnology to make two best-selling drugs - Enbrel, which is marketed to treat rheumatoid arthritis an ... more
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced results from the completed Phase IIa trial of BCX-4208 in patients with moderate to severe plaque psoriasis. ... more
The agency say the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen existing warnings in the prescribing info and medication guides due to risks of developing histoplasmosis, an o ... more
Biotechnology company Arana Therapeutics Limited (ASX: AAH) announced that it has completed recruitment in its Phase II dose-ranging psoriasis study for its anti-inflammatory drug ART621. Completion o ... more
Doctors tout drugs called biologics during Psoriasis Awareness Month. Source: HealthDay ... more
Psoriasis, one of humanity's oldest known diseases, has also been one of its most misunderstood. But in a new study that could change researchers' perspective of the skin disorder and potentially lead ... more
Xamiol® - LEO Pharma's new drug for treatment of scalp psoriasis - has been approved in 16 European countries. The UK will be the first country to market Xamiol®. This will take place already in t ... more
Psoriasis is a chronic disease of the immune system that affects the skin. As many as 7.5 million Americans suffer from psoriasis, according to the National Institutes of Health. Unlike other diseases ... more
Multiple Sclerosis Psoriasis Rhinitis, Allergic, Perennial /div ... more
New data, generated by Thomas Jung and colleagues, at Novartis Exploratory Development, Switzerland, have indicated that a drug known currently as AEB071 can reduce the clinical symptoms of psoriasis, ... more
NeoStrata announced findings from an ongoing 12-week study that demonstrates benefits of a novel topically applied LCD (coal tar) solution (Psorent(TM)) versus calcipotriol cream (Dovonex(R)) in ... more
Results of a study published in the June issue of Arthritis and Rheumatism suggest that treatment with efalizumab for moderate to severe psoriasis may trigger psoriatic arthritis. Reuters Health Inf ... more
The European Commission announced a new 50mg Enbrel® (etanercept) once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel® twice weekly regimen for the treatment of patien ... more
Irritable Bowel Syndrome (IBS) Psoriasis and Psoriatic Disorders Crohn's Disease /div ... more
Earlier this year, Amgen went out of its way to disavow a widely publicized case study that suggested Enbrel, which is only approved for treating rheumatoid arthritis and psoriasis, may be useful in c ... more
HUMIRA (adalimumab) has today been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for adults with severe chronic plaque psoriasis.1 Adalimumab is ... more
For many of us the summer is a time to think about taking a break, enjoying long hot days in the sun, sitting on a beach or swimming in the sea. But for people living with a skin disease cal ... more
The National Institute for Health and Clinical Excellence (NICE) has published guidance on the use of adalimumab for the treatment of psoriasis in adults. ... more
Gastroesophageal Reflux Disease (GERD) Anxiety Disorders Psoriasis and Psoriatic Disorders /div ... more
Centocor, Inc. announced that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the U.S. Food and Drug Administration (FDA) has unanimously recommended the approval of ustekinumab, a ... more
But experts also express concern about psoriasis drug's possible risks for children; action follows agency warning that drug label needs strengthening. Source: HealthDay ... more
An experimental Johnson Johnson drug should be approved for treating adults with moderate or severe psoriasis, a advisory panel unanimously ruled Tuesday. Reuters Health Information ... more
Nice to see you again. #8216;Tis the middle of the week and that can mean only one thing - meetings, projects and deadlines coming at you. And the Blackberry keeps buzzing, too. Never fear, Pharmalot ... more